Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 25;15(17):3725.
doi: 10.3390/nu15173725.

Supplementing Vitamin D in Different Patient Groups to Reduce Deficiency

Affiliations

Supplementing Vitamin D in Different Patient Groups to Reduce Deficiency

Pawel Pludowski. Nutrients. .

Abstract

Introduction: Studies indicate a high prevalence of vitamin D deficiency in both the general population and at-risk groups. Given the association between vitamin D deficiency and various diseases, addressing this concern becomes crucial, especially in situations where routine monitoring is challenging.

Materials and methods: A systematic literature review of the current knowledge on vitamin D dosing in diverse at-risk populations and the application of the findings to a broader clinical perspective.

Results: The reviewed studies revealed a high prevalence of vitamin D deficiency among patients with musculoskeletal disorders, systemic connective tissue diseases, corticosteroid use, endocrine and metabolic conditions, malabsorption syndromes, obesity, chronic kidney disease, cancer, and central nervous system diseases. Vitamin D deficiency was often more severe compared to the general population. Higher dosages of vitamin D beyond the recommended levels for the general population were shown to be effective in improving vitamin D status in these at-risk individuals. Additionally, some studies suggested a potential link between intermittent vitamin D administration and improved adherence.

Conclusion: Simplified dosing could empower clinicians to address vitamin D deficiency, particularly in high-risk populations, even without routine monitoring. Further research is needed to establish the optimal dosing regimens for specific at-risk populations.

Keywords: cholecalciferol; general population; risk groups; routine monitoring; vitamin D deficiency.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Similar articles

Cited by

References

    1. Płudowski P., Kos-Kudła B., Walczak M., Fal A., Zozulińska-Ziółkiewicz D., Sieroszewski P., Peregud-Pogorzelski J., Lauterbach R., Targowski T., Lewiński A., et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023;15:695. doi: 10.3390/nu15030695. - DOI - PMC - PubMed
    1. De Martinis M., Allegra A., Sirufo M.M., Tonacci A., Pioggia G., Raggiunti M., Ginaldi L., Gangemi S. Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review. Int. J. Mol. Sci. 2021;22:8855. doi: 10.3390/ijms22168855. - DOI - PMC - PubMed
    1. Pludowski P., Takacs I., Boyanov M., Belaya Z., Diaconu C.C., Mokhort T., Zherdova N., Rasa I., Payer J., Pilz S. Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement. Nutrients. 2022;14:1483. doi: 10.3390/nu14071483. - DOI - PMC - PubMed
    1. Takacs I., Bakos B., Nemeth Z., Toth B.E., Szili B., Lakatos P. Controlled randomized open label clinical study comparing the safety and efficacy of loading schedules in vitamin D deficient patients. J. Steroid Biochem. Mol. Biol. 2023;231:106330. doi: 10.1016/j.jsbmb.2023.106330. - DOI - PubMed
    1. Rothen J.-P., Rutishauser J., Walter P.N., Hersberger K.E., Arnet I. Vitamin D oral intermittent treatment (DO IT) study, a randomized clinical trial with individual loading regimen. Sci. Rep. 2021;11:18746. doi: 10.1038/s41598-021-97417-x. - DOI - PMC - PubMed

Publication types